Reportable Segment — Total Revenue
Biogen Reportable Segment — Total Revenue increased by 8.7% to $2.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.9%, from $2.43B to $2.48B. Over 3 years (FY 2022 to FY 2025), Reportable Segment — Total Revenue shows relatively stable performance with a -0.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful product adoption or market expansion, while a decrease suggests competitive pressure or product lifecycle maturity.
Detailed definition
This represents the total gross income generated by the primary business segment through the sale of pharmaceutical prod...
Peer comparison
Standard across all pharmaceutical companies as 'Segment Revenue' or 'Net Product Sales'.
biib_segment_reportable_segment_total_revenueHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.54B | $2.54B | $2.54B | $2.54B | $2.46B | $2.46B | $2.46B | $2.46B | $2.29B | $2.46B | $2.47B | $2.45B | $2.43B | $2.65B | $2.53B | $2.28B | $2.48B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -3.3% | +0.0% | +0.0% | +0.0% | -6.8% | +7.6% | +0.0% | -0.5% | -1.0% | +8.8% | -4.2% | -10.1% | +8.7% |
| YoY Change | — | — | — | — | -3.3% | -3.3% | -3.3% | -3.3% | -6.8% | +0.2% | +0.3% | -0.2% | +6.1% | +7.3% | +2.8% | -7.1% | +1.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's reportable segment — total revenue?
- Biogen (BIIB) reported reportable segment — total revenue of $2.48B in Q1 2026.
- How has Biogen's reportable segment — total revenue changed year-over-year?
- Biogen's reportable segment — total revenue increased by 1.9% year-over-year, from $2.43B to $2.48B.
- What is the long-term trend for Biogen's reportable segment — total revenue?
- Over 3 years (2022 to 2025), Biogen's reportable segment — total revenue has grown at a -0.9% compound annual growth rate (CAGR), from $10.17B to $9.89B.
- What does reportable segment — total revenue mean?
- The total sales revenue generated by the company's primary business segment.